These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 4090570)

  • 21. Sequential designs for equivalence studies.
    Whitehead J
    Stat Med; 1996 Dec; 15(24):2703-15. PubMed ID: 8981681
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Statistics for nuclear medicine. Part 6: Normal values, evaluating a new diagnostic procedure, sequential methods, and conclusion.
    O'Brien PC; Shampo MA; Robertson JS
    J Nucl Med; 1983 Jun; 24(6):535-41. PubMed ID: 6854403
    [No Abstract]   [Full Text] [Related]  

  • 23. The nature of evidence.
    Lasagna L
    Triangle; 1972; 11(4):145-52. PubMed ID: 4658379
    [No Abstract]   [Full Text] [Related]  

  • 24. [On the calculation and the evaluation of combinations of active substances (author's transl)].
    Groeger U; Lang S; Michel HJ
    Pharmazie; 1981; 36(2):81-7. PubMed ID: 7232493
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Statistical designs for experiments in combination therapy.
    Miller I
    Cancer Chemother Rep 2; 1974 Mar; 4(1):151-6. PubMed ID: 4826494
    [No Abstract]   [Full Text] [Related]  

  • 26. On biological assays involving quantal responses.
    Waud DR
    J Pharmacol Exp Ther; 1972 Dec; 183(3):577-607. PubMed ID: 4636393
    [No Abstract]   [Full Text] [Related]  

  • 27. Down with multiple t-tests.
    Elashoff JD
    Gastroenterology; 1981 Mar; 80(3):615-20. PubMed ID: 7450453
    [No Abstract]   [Full Text] [Related]  

  • 28. Reflections on the future of hormesis.
    Chapman PM
    Crit Rev Toxicol; 2001 Jul; 31(4-5):649-51. PubMed ID: 11504190
    [No Abstract]   [Full Text] [Related]  

  • 29. [Statistical basis for the absence of a threshold of action for carcinogenic factors on a population level].
    Ivanov VI
    Vopr Onkol; 1983; 29(6):100-4. PubMed ID: 6868471
    [No Abstract]   [Full Text] [Related]  

  • 30. 'Truth in packaging?' The unwrapping of epidemiologic research.
    Lanes SF; Poole C
    J Occup Med; 1984 Aug; 26(8):571-4. PubMed ID: 6481496
    [No Abstract]   [Full Text] [Related]  

  • 31. Group sequential test strategies for superiority and non-inferiority hypotheses in active controlled clinical trials.
    Wang SJ; Hung HM; Tsong Y; Cui L
    Stat Med; 2001 Jul; 20(13):1903-12. PubMed ID: 11427948
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Weibull distributions for continuous-carcinogenesis experiments.
    Peto R; Lee P
    Biometrics; 1973 Sep; 29(3):457-70. PubMed ID: 4793135
    [No Abstract]   [Full Text] [Related]  

  • 33. The estimation of relative potency from two parabolas in symmetric bioassays.
    Williams DA
    Biometrics; 1973 Dec; 29(4):695-700. PubMed ID: 4785234
    [No Abstract]   [Full Text] [Related]  

  • 34. Patient specific dosing in a cancer phase I clinical trial.
    Babb JS; Rogatko A
    Stat Med; 2001 Jul; 20(14):2079-90. PubMed ID: 11439422
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dose-finding study of ibuprofen in patent ductus arteriosus using the continual reassessment method.
    Desfrere L; Zohar S; Morville P; Brunhes A; Chevret S; Pons G; Moriette G; Rey E; Treluyer JM
    J Clin Pharm Ther; 2005 Apr; 30(2):121-32. PubMed ID: 15811164
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nonoccupational exposure to chrysotile asbestos and the risk of lung cancer.
    Costas E; Garrido A; Goyanes VJ
    N Engl J Med; 1998 Oct; 339(14):1000; author reply 1001-2. PubMed ID: 9766979
    [No Abstract]   [Full Text] [Related]  

  • 37. Basic requirements for long-term assays for carcinogenicity.
    Feron VJ; Grice HC; Griesemer R; Peto R; Agthe C; Althoff J; Arnold DL; Blumenthal H; Cabral JR; Della Porta G; Ito N; Kimmerle G; Kroes R; Mohr U; Napalkov NP; Odashima S; Page NP; Schramm T; Steinhoff D; Sugar J; Tomatis L; Uehleke H; Vouk V
    IARC Monogr Eval Carcinog Risk Chem Hum Suppl; 1980; (2 Suppl):21-83. PubMed ID: 6935180
    [No Abstract]   [Full Text] [Related]  

  • 38. Quantitative and statistical analysis of the association between in vitro and in vivo studies.
    Moon TE
    Prog Clin Biol Res; 1980; 48():209-21. PubMed ID: 7193871
    [No Abstract]   [Full Text] [Related]  

  • 39. Statistics for clinicians. 12. Sequential methods.
    O'Brien PC; Shampo MA
    Mayo Clin Proc; 1981 Dec; 56(12):753-4. PubMed ID: 7311603
    [No Abstract]   [Full Text] [Related]  

  • 40. Multiscale modeling of the causal functional roles of nsSNPs in a genome-wide association study: application to hypoxia.
    Xie L; Ng C; Ali T; Valencia R; Ferreira BL; Xue V; Tanweer M; Zhou D; Haddad GG; Bourne PE; Xie L
    BMC Genomics; 2013; 14 Suppl 3(Suppl 3):S9. PubMed ID: 23819581
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.